Journals / Ahi Evran Tıp Dergisi / 2022 / Cilt: 6 - Sayı: 3

Evaluation of Fibromyalgia Frequency in Chronic Urticaria Patients and Its Association with Urticaria Severity

Kronik Ürtiker Hastalarında Fibromiyalji Sendromu Sıklığının Değerlendirilmesi

Pages
276–281
Publication Date
2022-12-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This may be related to the chronic effect of neuromediators involved in chronic urticaria pathogenesis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Chronic urticaria is a skin disease with unknown etiology.
📊
Key Findings & Data:The aim of the study was to determine the frequency and severity of fibromyalgia and the effect of fibromyalgia coexistence on clinical features and dermatology life quality index in urticaria patients.Materials and Methods: One hundred patients with chronic urticaria and no history of any systemic disease and 100 age and sexmatched healthy controls were included.
💡
Conclusion & Impact:This may be related to the chronic effect of neuromediators involved in chronic urticaria pathogenesis.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:fibromiyalji · kaşıntı · kronik ürtiker

Abstract

Purpose: Chronic urticaria is a skin disease with unknown etiology. Autoimmunity and psychogenic factors have been suggested to play a role in pathogenesis. Fibromyalgia is a rheumatic disease that may be associated with psychogenic factors. The aim of the study was to determine the frequency and severity of fibromyalgia and the effect of fibromyalgia coexistence on clinical features and dermatology life quality index in urticaria patients.Materials and Methods: One hundred patients with chronic urticaria and no history of any systemic disease and 100 age and sexmatched healthy controls were included. Urticaria severity was evaluated by the dermatology life quality index (DLQI). Clinical severity and disability status were evaluated by the visual analog scale (VAS) and fibromyalgia impact questionnaire (FIQ).Results: The mean age of the chronic urticaria patient group was 37.7±1.32, and that was 40.7±11.2 in the control group (p=0.09). Fibromyalgia frequency (45%) in the chronic urticaria group was significantly higher than in the control group (13%) (p=0.00). The duration of chronic urticaria was significantly higher in the patients with FMS than in the patients without FMS (p=0.001). There was a statistically significant correlation between FIQ and DLQI (p=0.019). No significant differences in terms of FMS durations, VAS, and FIQ values were detected between groups (p=0.432, p=0.201, p=0.332).Conclusion: High frequency of fibromyalgia in chronic urticaria patients was found. This may be related to the chronic effect of neuromediators involved in chronic urticaria pathogenesis.

Özet

Amaç: Kronik ürtiker, nedeni tam olarak aydınlatılamamış kaşıntılı bir deri hastalığıdır. Otoimmünite ve psikojenik faktörlerin de patogenezde rolü olabileceği düşünülmektedir. Fibromiyalji sendromu (FMS) psikojenik nedenlerle ilişkili olabileceği düşünülen bir romatizmal hastalıktır. Çalışmamızda kronik ürtiker hastalarında FMS sıklığı ve şiddetini araştırmayı ve kronik ürtikere eşlik eden fibromiyalji varlığının klinik özelliklere ve dermatoloji yaşam kalitesine etkisini değerlendirmeyi planladık.Araçlar ve Yöntem: Çalışmaya kronik ürtiker tanısı almış ve sistemik hastalık öyküsü olmayan 100 hasta, yaş ve cinsiyet açısından eşleştirilmiş 100 sağlıklı kontrol dahil edildi. Ürtiker şiddeti dermatoloji yaşam kalite indeksi skorları (DYKI) hesaplanarak değerlendirildi. Klinik şiddet ve fonksiyonel disabilite durumları vizuel analog skala (VAS) ve fibromiyalji etki anketi (FIQ) ile değerlendirildi.Bulgular: Hasta grubunun yaş ortalaması 37.7±1.32, kontrol grubunun ise 40.7±11.2 olarak saptandı (p=0.09). Hasta grubundaki FMS sıklığı (%45) kontrol grubundan (%13) istatistiksel olarak anlamlı şekilde yüksekti (p=0.00). Kronik ürtiker süresi FMS'li hastalarda istatistiksel olarak anlamlı derecede yüksek bulundu(p=0.001). FIQ ve DLQI değerleri arasında istatistiksel olarak anlamlı korelasyon saptandı (p=0.019). Hasta ve kontrol grubunda FMS süreleri, VAS ve FIQ açısından istatistiksel olarak anlamlı fark saptanmadı (p=0.432, p=0.201, p=0.332).Sonuç: Kronik ürtiker hastalarında FMS sıklığının artmış olduğunu görülmektedir. Bu sonuç kronik ürtiker patogenezindeki nöromediatörlerin kronik dönemdeki etkileriyle ilişkili olabilir.

🔖

Cite This Article

ACAR, E. M., ŞAŞ, S. (2022). Evaluation of Fibromyalgia Frequency in Chronic Urticaria Patients and Its Association with Urticaria Severity. Ahi Evran Tıp Dergisi, Cilt: 6 - Sayı: 3, 276–281. https://ajindex.com/articles/866786

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Wedi B, Wieczorek D, Raap U, Kapp A. Urticaria. J Dtsch Dermatol Ges. 2014;12(11):997-1009
  2. Öztürk S, Erel F, Çalışkaner AZ, Karaayvaz M, Güleç M, Kartal Ö. Kronik İdiopatik Ürtiker’de Katkı Maddeli Gıdalar ile Doğal Gıdalarda Bulunan Vazoaktif Maddelerin Rolü. Kor. Hek. 2007;6(5):351-356
  3. Schocket AL. Chronic urticaria: pathophysiology and etiology, or the what and why. In Allergy Asthma Proc. 2006;27(2):90-95
  4. Colgecen E, Ozyurt K, Gul AI, Utas S. Evaluation of etiological factors in patients with chronic urticaria. Acta Dermatovenerologica Croat. 2015;23(1): 36-36
  5. Mathkhor AJ, Mohammed JQ. Prevalence of fibromyalgia syndrome in chronic urticaria. Middle East J Fam Med. 2020;7(10):102
  6. Torresani C, Bellafiore S, De Panfilis G. "Chronic urticaria is usually associated with fibromyalgia syndrome." Actaderm-venereol. 2009;89(4):389-392
  7. Oktayoglu P, Ucmak D, Caglayan M et al. Is there an association between chronic urticaria and fibromyalgia syndrome? Arch Rheumatol. 2014;29(1):28-34
  8. Steinhoff M, Stander S, Seeliger S et al. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol. 2003;39(11):1479-1488
  9. Littlejohn GO, Weinstein C, Helme RD. Increased neurogenic inflammation in fibrositis syndrome. J Rheumatol. 1987;14(5):1022-1025
  10. Eneström S, Bengtsson A, Frödin T. Dermal IgG deposits and increase of mast cells in patients with fibromyalgia relevant findings or epiphenomena? Scand J Rheumatol. 1997;26(4):308-313
  11. Hapa A, Ozdemir O, Evans SE et al. Evaluation of the frequency of fibromyalgia in patients with chronic urticarial. Turkderm. 2012;46(4):202-205
  12. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216
  13. Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45(11):1300-1307
  14. Jones KR, Vojir CP, Hutt E, Fink R. Determining mild, moderate, and severe pain, equivalency across pain-intensity tools in nursing home residents. J Rehabil Res Dev. 2007;44(2):305
  15. Paul SM, Zelman, DC, Smith M, Miaskowski C. Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain. 2005;113 (1-2):37-44
  16. Wolfe F, Clauw DJ, Fitzcharles M-A, et al., 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 2016;46(3):319-329
  17. Sarmer S, Ergin S, Yavuzer G.